Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Mounjaro (tirzepatide) currently shows the fastest and most significant weight loss results among GLP-1-related medications
Under the brand name Victoza, it's approved to treat type 2 diabetes, while under the brand name Saxenda, it's approved for weight loss
Beneficiaries who are prescribed an eligible GLP-1 drug for a use that is already coverable under the basic Medicare Part D benefit such as Zepbound for the treatment of moderate to severe obstructive sleep apnea, or Wegovy to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight would NOT qualify for coverage under the Medicare GLP-1 Bridge
41 : 17261732 Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ
The GSH level was calculated as 0.735 mM by applying the linear concentration curve on (C)
US$ 29.72
US$ 27.33
US$ 22.66
US$ 22.61
US$ 28.58
